← Open Payments lookup

EMILY HOLLOWAY: Open Payments

NPI 1790404952 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$954 in 10 payments from 9 companies in 2025. Trend: 2023 $417 · 2024 $690 · 2025 $954

Food & beverage: $954
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$258
Axsome Therapeutics, Inc.1$124
Otsuka America Pharmaceutical, Inc.1$123
Phathom Pharmaceuticals, Inc.1$122
ABBVIE INC.1$103
Medtronic, Inc.1$93
Supernus Pharmaceuticals, Inc.1$92
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21
Lilly USA, LLC1$19

Products named: CAPLYTA, Auvelity, REXULTI, VOQUEZNA, QULIPTA, INTELLIS ADAPTIVESTIM, Qelbree, XIFAXAN.

Industry payments across MS — which companies pay providers there.